Global PD-1 and PD-L1 Drug Market Growth 2026-2032
The global PD-1 and PD-L1 Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?PD-1 and PD-L1 Drug Industry Forecast? looks at past sales and reviews total world PD-1 and PD-L1 Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected PD-1 and PD-L1 Drug sales for 2026 through 2032. With PD-1 and PD-L1 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 and PD-L1 Drug industry.
This Insight Report provides a comprehensive analysis of the global PD-1 and PD-L1 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 and PD-L1 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global PD-1 and PD-L1 Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 and PD-L1 Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 and PD-L1 Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PD-L1 Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?PD-1 and PD-L1 Drug Industry Forecast? looks at past sales and reviews total world PD-1 and PD-L1 Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected PD-1 and PD-L1 Drug sales for 2026 through 2032. With PD-1 and PD-L1 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 and PD-L1 Drug industry.
This Insight Report provides a comprehensive analysis of the global PD-1 and PD-L1 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PD-1 and PD-L1 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global PD-1 and PD-L1 Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 and PD-L1 Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 and PD-L1 Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PD-L1 Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- PD-1 Monoclonal Antibody
- PD-L1 Monoclonal Antibody
- Liver Cancer
- Esophageal Cancer
- Nasal Cancer
- Stomach Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol Myers Squibb
- Merck & Co., Inc.
- F. Hoffmann -La Roche Ltd
- AstraZeneca
- Sanofi
- Pfizer Inc
- Lilly
- Novartis AG
- GSK
- Junshi Biosciences
- Akeso, Inc
- BeiGene
- Innovent
- Jiangsu Hengrui Medicine Co.,Ltd
- Cstone
- Henlius
- Simcere Pharmaceutical Group Limited
- What is the 10-year outlook for the global PD-1 and PD-L1 Drug market?
- What factors are driving PD-1 and PD-L1 Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do PD-1 and PD-L1 Drug market opportunities vary by end market size?
- How does PD-1 and PD-L1 Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 and PD-L1 Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Drug by Country/Region, 2021, 2025 & 2032
2.2 PD-1 and PD-L1 Drug Segment by Type
2.2.1 PD-1 Monoclonal Antibody
2.2.2 PD-L1 Monoclonal Antibody
2.2.3 PD-1 and PD-L1 Drug Sales by Type
2.2.3.1 Global PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global PD-1 and PD-L1 Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global PD-1 and PD-L1 Drug Sale Price by Type (2021-2026)
2.3 PD-1 and PD-L1 Drug Segment by Application
2.3.1 Liver Cancer
2.3.2 Esophageal Cancer
2.3.3 Nasal Cancer
2.3.4 Stomach Cancer
2.3.5 Other
2.3.6 PD-1 and PD-L1 Drug Sales by Application
2.3.6.1 Global PD-1 and PD-L1 Drug Sale Market Share by Application (2021-2026)
2.3.6.2 Global PD-1 and PD-L1 Drug Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global PD-1 and PD-L1 Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PD-1 and PD-L1 Drug Breakdown Data by Company
3.1.1 Global PD-1 and PD-L1 Drug Annual Sales by Company (2021-2026)
3.1.2 Global PD-1 and PD-L1 Drug Sales Market Share by Company (2021-2026)
3.2 Global PD-1 and PD-L1 Drug Annual Revenue by Company (2021-2026)
3.2.1 Global PD-1 and PD-L1 Drug Revenue by Company (2021-2026)
3.2.2 Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2021-2026)
3.3 Global PD-1 and PD-L1 Drug Sale Price by Company
3.4 Key Manufacturers PD-1 and PD-L1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 and PD-L1 Drug Product Location Distribution
3.4.2 Players PD-1 and PD-L1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PD-1 AND PD-L1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic PD-1 and PD-L1 Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global PD-1 and PD-L1 Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PD-1 and PD-L1 Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PD-1 and PD-L1 Drug Market Size by Country/Region (2021-2026)
4.2.1 Global PD-1 and PD-L1 Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global PD-1 and PD-L1 Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas PD-1 and PD-L1 Drug Sales Growth
4.4 APAC PD-1 and PD-L1 Drug Sales Growth
4.5 Europe PD-1 and PD-L1 Drug Sales Growth
4.6 Middle East & Africa PD-1 and PD-L1 Drug Sales Growth
5 AMERICAS
5.1 Americas PD-1 and PD-L1 Drug Sales by Country
5.1.1 Americas PD-1 and PD-L1 Drug Sales by Country (2021-2026)
5.1.2 Americas PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
5.2 Americas PD-1 and PD-L1 Drug Sales by Type (2021-2026)
5.3 Americas PD-1 and PD-L1 Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 and PD-L1 Drug Sales by Region
6.1.1 APAC PD-1 and PD-L1 Drug Sales by Region (2021-2026)
6.1.2 APAC PD-1 and PD-L1 Drug Revenue by Region (2021-2026)
6.2 APAC PD-1 and PD-L1 Drug Sales by Type (2021-2026)
6.3 APAC PD-1 and PD-L1 Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 and PD-L1 Drug by Country
7.1.1 Europe PD-1 and PD-L1 Drug Sales by Country (2021-2026)
7.1.2 Europe PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
7.2 Europe PD-1 and PD-L1 Drug Sales by Type (2021-2026)
7.3 Europe PD-1 and PD-L1 Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 and PD-L1 Drug by Country
8.1.1 Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa PD-1 and PD-L1 Drug Sales by Type (2021-2026)
8.3 Middle East & Africa PD-1 and PD-L1 Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Drug
10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Drug
10.4 Industry Chain Structure of PD-1 and PD-L1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 and PD-L1 Drug Distributors
11.3 PD-1 and PD-L1 Drug Customer
12 WORLD FORECAST REVIEW FOR PD-1 AND PD-L1 DRUG BY GEOGRAPHIC REGION
12.1 Global PD-1 and PD-L1 Drug Market Size Forecast by Region
12.1.1 Global PD-1 and PD-L1 Drug Forecast by Region (2027-2032)
12.1.2 Global PD-1 and PD-L1 Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PD-1 and PD-L1 Drug Forecast by Type (2027-2032)
12.7 Global PD-1 and PD-L1 Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Merck & Co., Inc.
13.2.1 Merck & Co., Inc. Company Information
13.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck & Co., Inc. Main Business Overview
13.2.5 Merck & Co., Inc. Latest Developments
13.3 F. Hoffmann -La Roche Ltd
13.3.1 F. Hoffmann -La Roche Ltd Company Information
13.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 F. Hoffmann -La Roche Ltd Main Business Overview
13.3.5 F. Hoffmann -La Roche Ltd Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Pfizer Inc
13.6.1 Pfizer Inc Company Information
13.6.2 Pfizer Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Inc Main Business Overview
13.6.5 Pfizer Inc Latest Developments
13.7 Lilly
13.7.1 Lilly Company Information
13.7.2 Lilly PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lilly Main Business Overview
13.7.5 Lilly Latest Developments
13.8 Novartis AG
13.8.1 Novartis AG Company Information
13.8.2 Novartis AG PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novartis AG Main Business Overview
13.8.5 Novartis AG Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Junshi Biosciences
13.10.1 Junshi Biosciences Company Information
13.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Junshi Biosciences Main Business Overview
13.10.5 Junshi Biosciences Latest Developments
13.11 Akeso, Inc
13.11.1 Akeso, Inc Company Information
13.11.2 Akeso, Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Akeso, Inc Main Business Overview
13.11.5 Akeso, Inc Latest Developments
13.12 BeiGene
13.12.1 BeiGene Company Information
13.12.2 BeiGene PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BeiGene Main Business Overview
13.12.5 BeiGene Latest Developments
13.13 Innovent
13.13.1 Innovent Company Information
13.13.2 Innovent PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Innovent Main Business Overview
13.13.5 Innovent Latest Developments
13.14 Jiangsu Hengrui Medicine Co.,Ltd
13.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
13.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Hengrui Medicine Co.,Ltd Main Business Overview
13.14.5 Jiangsu Hengrui Medicine Co.,Ltd Latest Developments
13.15 Cstone
13.15.1 Cstone Company Information
13.15.2 Cstone PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Cstone Main Business Overview
13.15.5 Cstone Latest Developments
13.16 Henlius
13.16.1 Henlius Company Information
13.16.2 Henlius PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Henlius Main Business Overview
13.16.5 Henlius Latest Developments
13.17 Simcere Pharmaceutical Group Limited
13.17.1 Simcere Pharmaceutical Group Limited Company Information
13.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Simcere Pharmaceutical Group Limited Main Business Overview
13.17.5 Simcere Pharmaceutical Group Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PD-1 and PD-L1 Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Drug by Country/Region, 2021, 2025 & 2032
2.2 PD-1 and PD-L1 Drug Segment by Type
2.2.1 PD-1 Monoclonal Antibody
2.2.2 PD-L1 Monoclonal Antibody
2.2.3 PD-1 and PD-L1 Drug Sales by Type
2.2.3.1 Global PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global PD-1 and PD-L1 Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global PD-1 and PD-L1 Drug Sale Price by Type (2021-2026)
2.3 PD-1 and PD-L1 Drug Segment by Application
2.3.1 Liver Cancer
2.3.2 Esophageal Cancer
2.3.3 Nasal Cancer
2.3.4 Stomach Cancer
2.3.5 Other
2.3.6 PD-1 and PD-L1 Drug Sales by Application
2.3.6.1 Global PD-1 and PD-L1 Drug Sale Market Share by Application (2021-2026)
2.3.6.2 Global PD-1 and PD-L1 Drug Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global PD-1 and PD-L1 Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global PD-1 and PD-L1 Drug Breakdown Data by Company
3.1.1 Global PD-1 and PD-L1 Drug Annual Sales by Company (2021-2026)
3.1.2 Global PD-1 and PD-L1 Drug Sales Market Share by Company (2021-2026)
3.2 Global PD-1 and PD-L1 Drug Annual Revenue by Company (2021-2026)
3.2.1 Global PD-1 and PD-L1 Drug Revenue by Company (2021-2026)
3.2.2 Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2021-2026)
3.3 Global PD-1 and PD-L1 Drug Sale Price by Company
3.4 Key Manufacturers PD-1 and PD-L1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PD-1 and PD-L1 Drug Product Location Distribution
3.4.2 Players PD-1 and PD-L1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PD-1 AND PD-L1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic PD-1 and PD-L1 Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global PD-1 and PD-L1 Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global PD-1 and PD-L1 Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic PD-1 and PD-L1 Drug Market Size by Country/Region (2021-2026)
4.2.1 Global PD-1 and PD-L1 Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global PD-1 and PD-L1 Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas PD-1 and PD-L1 Drug Sales Growth
4.4 APAC PD-1 and PD-L1 Drug Sales Growth
4.5 Europe PD-1 and PD-L1 Drug Sales Growth
4.6 Middle East & Africa PD-1 and PD-L1 Drug Sales Growth
5 AMERICAS
5.1 Americas PD-1 and PD-L1 Drug Sales by Country
5.1.1 Americas PD-1 and PD-L1 Drug Sales by Country (2021-2026)
5.1.2 Americas PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
5.2 Americas PD-1 and PD-L1 Drug Sales by Type (2021-2026)
5.3 Americas PD-1 and PD-L1 Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-1 and PD-L1 Drug Sales by Region
6.1.1 APAC PD-1 and PD-L1 Drug Sales by Region (2021-2026)
6.1.2 APAC PD-1 and PD-L1 Drug Revenue by Region (2021-2026)
6.2 APAC PD-1 and PD-L1 Drug Sales by Type (2021-2026)
6.3 APAC PD-1 and PD-L1 Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PD-1 and PD-L1 Drug by Country
7.1.1 Europe PD-1 and PD-L1 Drug Sales by Country (2021-2026)
7.1.2 Europe PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
7.2 Europe PD-1 and PD-L1 Drug Sales by Type (2021-2026)
7.3 Europe PD-1 and PD-L1 Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PD-1 and PD-L1 Drug by Country
8.1.1 Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa PD-1 and PD-L1 Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa PD-1 and PD-L1 Drug Sales by Type (2021-2026)
8.3 Middle East & Africa PD-1 and PD-L1 Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Drug
10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Drug
10.4 Industry Chain Structure of PD-1 and PD-L1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PD-1 and PD-L1 Drug Distributors
11.3 PD-1 and PD-L1 Drug Customer
12 WORLD FORECAST REVIEW FOR PD-1 AND PD-L1 DRUG BY GEOGRAPHIC REGION
12.1 Global PD-1 and PD-L1 Drug Market Size Forecast by Region
12.1.1 Global PD-1 and PD-L1 Drug Forecast by Region (2027-2032)
12.1.2 Global PD-1 and PD-L1 Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global PD-1 and PD-L1 Drug Forecast by Type (2027-2032)
12.7 Global PD-1 and PD-L1 Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Merck & Co., Inc.
13.2.1 Merck & Co., Inc. Company Information
13.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck & Co., Inc. Main Business Overview
13.2.5 Merck & Co., Inc. Latest Developments
13.3 F. Hoffmann -La Roche Ltd
13.3.1 F. Hoffmann -La Roche Ltd Company Information
13.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 F. Hoffmann -La Roche Ltd Main Business Overview
13.3.5 F. Hoffmann -La Roche Ltd Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Pfizer Inc
13.6.1 Pfizer Inc Company Information
13.6.2 Pfizer Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Inc Main Business Overview
13.6.5 Pfizer Inc Latest Developments
13.7 Lilly
13.7.1 Lilly Company Information
13.7.2 Lilly PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lilly Main Business Overview
13.7.5 Lilly Latest Developments
13.8 Novartis AG
13.8.1 Novartis AG Company Information
13.8.2 Novartis AG PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novartis AG Main Business Overview
13.8.5 Novartis AG Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Junshi Biosciences
13.10.1 Junshi Biosciences Company Information
13.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Junshi Biosciences Main Business Overview
13.10.5 Junshi Biosciences Latest Developments
13.11 Akeso, Inc
13.11.1 Akeso, Inc Company Information
13.11.2 Akeso, Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Akeso, Inc Main Business Overview
13.11.5 Akeso, Inc Latest Developments
13.12 BeiGene
13.12.1 BeiGene Company Information
13.12.2 BeiGene PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BeiGene Main Business Overview
13.12.5 BeiGene Latest Developments
13.13 Innovent
13.13.1 Innovent Company Information
13.13.2 Innovent PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Innovent Main Business Overview
13.13.5 Innovent Latest Developments
13.14 Jiangsu Hengrui Medicine Co.,Ltd
13.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
13.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Hengrui Medicine Co.,Ltd Main Business Overview
13.14.5 Jiangsu Hengrui Medicine Co.,Ltd Latest Developments
13.15 Cstone
13.15.1 Cstone Company Information
13.15.2 Cstone PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Cstone Main Business Overview
13.15.5 Cstone Latest Developments
13.16 Henlius
13.16.1 Henlius Company Information
13.16.2 Henlius PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Henlius Main Business Overview
13.16.5 Henlius Latest Developments
13.17 Simcere Pharmaceutical Group Limited
13.17.1 Simcere Pharmaceutical Group Limited Company Information
13.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Portfolios and Specifications
13.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Simcere Pharmaceutical Group Limited Main Business Overview
13.17.5 Simcere Pharmaceutical Group Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PD-1 and PD-L1 Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PD-1 and PD-L1 Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PD-1 Monoclonal Antibody
Table 4. Major Players of PD-L1 Monoclonal Antibody
Table 5. Global PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Table 7. Global PD-1 and PD-L1 Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2021-2026)
Table 9. Global PD-1 and PD-L1 Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global PD-1 and PD-L1 Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global PD-1 and PD-L1 Drug Sale Market Share by Application (2021-2026)
Table 12. Global PD-1 and PD-L1 Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2021-2026)
Table 14. Global PD-1 and PD-L1 Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global PD-1 and PD-L1 Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global PD-1 and PD-L1 Drug Sales Market Share by Company (2021-2026)
Table 17. Global PD-1 and PD-L1 Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2021-2026)
Table 19. Global PD-1 and PD-L1 Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers PD-1 and PD-L1 Drug Producing Area Distribution and Sales Area
Table 21. Players PD-1 and PD-L1 Drug Products Offered
Table 22. PD-1 and PD-L1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PD-1 and PD-L1 Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global PD-1 and PD-L1 Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global PD-1 and PD-L1 Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global PD-1 and PD-L1 Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global PD-1 and PD-L1 Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global PD-1 and PD-L1 Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global PD-1 and PD-L1 Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas PD-1 and PD-L1 Drug Sales Market Share by Country (2021-2026)
Table 35. Americas PD-1 and PD-L1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC PD-1 and PD-L1 Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC PD-1 and PD-L1 Drug Sales Market Share by Region (2021-2026)
Table 40. APAC PD-1 and PD-L1 Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe PD-1 and PD-L1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Drug
Table 52. Key Market Challenges & Risks of PD-1 and PD-L1 Drug
Table 53. Key Industry Trends of PD-1 and PD-L1 Drug
Table 54. PD-1 and PD-L1 Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PD-1 and PD-L1 Drug Distributors List
Table 57. PD-1 and PD-L1 Drug Customer List
Table 58. Global PD-1 and PD-L1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global PD-1 and PD-L1 Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas PD-1 and PD-L1 Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC PD-1 and PD-L1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC PD-1 and PD-L1 Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe PD-1 and PD-L1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa PD-1 and PD-L1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global PD-1 and PD-L1 Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global PD-1 and PD-L1 Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global PD-1 and PD-L1 Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global PD-1 and PD-L1 Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bristol Myers Squibb Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol Myers Squibb PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 74. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bristol Myers Squibb Main Business
Table 76. Bristol Myers Squibb Latest Developments
Table 77. Merck & Co., Inc. Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck & Co., Inc. PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 79. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck & Co., Inc. Main Business
Table 81. Merck & Co., Inc. Latest Developments
Table 82. F. Hoffmann -La Roche Ltd Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 84. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. F. Hoffmann -La Roche Ltd Main Business
Table 86. F. Hoffmann -La Roche Ltd Latest Developments
Table 87. AstraZeneca Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 89. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Sanofi Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 94. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Pfizer Inc Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 99. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Pfizer Inc Main Business
Table 101. Pfizer Inc Latest Developments
Table 102. Lilly Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Lilly PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 104. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lilly Main Business
Table 106. Lilly Latest Developments
Table 107. Novartis AG Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis AG PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 109. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Novartis AG Main Business
Table 111. Novartis AG Latest Developments
Table 112. GSK Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 114. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 117. Junshi Biosciences Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 119. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Junshi Biosciences Main Business
Table 121. Junshi Biosciences Latest Developments
Table 122. Akeso, Inc Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 124. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Akeso, Inc Main Business
Table 126. Akeso, Inc Latest Developments
Table 127. BeiGene Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. BeiGene PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 129. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. BeiGene Main Business
Table 131. BeiGene Latest Developments
Table 132. Innovent Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Innovent PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 134. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Innovent Main Business
Table 136. Innovent Latest Developments
Table 137. Jiangsu Hengrui Medicine Co.,Ltd Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 139. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Hengrui Medicine Co.,Ltd Main Business
Table 141. Jiangsu Hengrui Medicine Co.,Ltd Latest Developments
Table 142. Cstone Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Cstone PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 144. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Cstone Main Business
Table 146. Cstone Latest Developments
Table 147. Henlius Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Henlius PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 149. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Henlius Main Business
Table 151. Henlius Latest Developments
Table 152. Simcere Pharmaceutical Group Limited Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 154. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Simcere Pharmaceutical Group Limited Main Business
Table 156. Simcere Pharmaceutical Group Limited Latest Developments
Table 1. PD-1 and PD-L1 Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. PD-1 and PD-L1 Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PD-1 Monoclonal Antibody
Table 4. Major Players of PD-L1 Monoclonal Antibody
Table 5. Global PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Table 7. Global PD-1 and PD-L1 Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2021-2026)
Table 9. Global PD-1 and PD-L1 Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global PD-1 and PD-L1 Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global PD-1 and PD-L1 Drug Sale Market Share by Application (2021-2026)
Table 12. Global PD-1 and PD-L1 Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2021-2026)
Table 14. Global PD-1 and PD-L1 Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global PD-1 and PD-L1 Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global PD-1 and PD-L1 Drug Sales Market Share by Company (2021-2026)
Table 17. Global PD-1 and PD-L1 Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global PD-1 and PD-L1 Drug Revenue Market Share by Company (2021-2026)
Table 19. Global PD-1 and PD-L1 Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers PD-1 and PD-L1 Drug Producing Area Distribution and Sales Area
Table 21. Players PD-1 and PD-L1 Drug Products Offered
Table 22. PD-1 and PD-L1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PD-1 and PD-L1 Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global PD-1 and PD-L1 Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global PD-1 and PD-L1 Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global PD-1 and PD-L1 Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global PD-1 and PD-L1 Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global PD-1 and PD-L1 Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global PD-1 and PD-L1 Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas PD-1 and PD-L1 Drug Sales Market Share by Country (2021-2026)
Table 35. Americas PD-1 and PD-L1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC PD-1 and PD-L1 Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC PD-1 and PD-L1 Drug Sales Market Share by Region (2021-2026)
Table 40. APAC PD-1 and PD-L1 Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe PD-1 and PD-L1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa PD-1 and PD-L1 Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa PD-1 and PD-L1 Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Drug
Table 52. Key Market Challenges & Risks of PD-1 and PD-L1 Drug
Table 53. Key Industry Trends of PD-1 and PD-L1 Drug
Table 54. PD-1 and PD-L1 Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PD-1 and PD-L1 Drug Distributors List
Table 57. PD-1 and PD-L1 Drug Customer List
Table 58. Global PD-1 and PD-L1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global PD-1 and PD-L1 Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas PD-1 and PD-L1 Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC PD-1 and PD-L1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC PD-1 and PD-L1 Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe PD-1 and PD-L1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa PD-1 and PD-L1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa PD-1 and PD-L1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global PD-1 and PD-L1 Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global PD-1 and PD-L1 Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global PD-1 and PD-L1 Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global PD-1 and PD-L1 Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bristol Myers Squibb Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Bristol Myers Squibb PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 74. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bristol Myers Squibb Main Business
Table 76. Bristol Myers Squibb Latest Developments
Table 77. Merck & Co., Inc. Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck & Co., Inc. PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 79. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck & Co., Inc. Main Business
Table 81. Merck & Co., Inc. Latest Developments
Table 82. F. Hoffmann -La Roche Ltd Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 84. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. F. Hoffmann -La Roche Ltd Main Business
Table 86. F. Hoffmann -La Roche Ltd Latest Developments
Table 87. AstraZeneca Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 89. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Sanofi Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 94. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. Pfizer Inc Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 99. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Pfizer Inc Main Business
Table 101. Pfizer Inc Latest Developments
Table 102. Lilly Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Lilly PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 104. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lilly Main Business
Table 106. Lilly Latest Developments
Table 107. Novartis AG Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis AG PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 109. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Novartis AG Main Business
Table 111. Novartis AG Latest Developments
Table 112. GSK Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. GSK PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 114. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GSK Main Business
Table 116. GSK Latest Developments
Table 117. Junshi Biosciences Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 119. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Junshi Biosciences Main Business
Table 121. Junshi Biosciences Latest Developments
Table 122. Akeso, Inc Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 124. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Akeso, Inc Main Business
Table 126. Akeso, Inc Latest Developments
Table 127. BeiGene Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. BeiGene PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 129. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. BeiGene Main Business
Table 131. BeiGene Latest Developments
Table 132. Innovent Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Innovent PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 134. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Innovent Main Business
Table 136. Innovent Latest Developments
Table 137. Jiangsu Hengrui Medicine Co.,Ltd Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 139. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Hengrui Medicine Co.,Ltd Main Business
Table 141. Jiangsu Hengrui Medicine Co.,Ltd Latest Developments
Table 142. Cstone Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Cstone PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 144. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Cstone Main Business
Table 146. Cstone Latest Developments
Table 147. Henlius Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Henlius PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 149. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Henlius Main Business
Table 151. Henlius Latest Developments
Table 152. Simcere Pharmaceutical Group Limited Basic Information, PD-1 and PD-L1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Portfolios and Specifications
Table 154. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Simcere Pharmaceutical Group Limited Main Business
Table 156. Simcere Pharmaceutical Group Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of PD-1 and PD-L1 Drug
Figure 2. PD-1 and PD-L1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 and PD-L1 Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global PD-1 and PD-L1 Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PD-1 and PD-L1 Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2025)
Figure 10. PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of PD-1 Monoclonal Antibody
Figure 12. Product Picture of PD-L1 Monoclonal Antibody
Figure 13. Global PD-1 and PD-L1 Drug Sales Market Share by Type in 2026
Figure 14. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2021-2026)
Figure 15. PD-1 and PD-L1 Drug Consumed in Liver Cancer
Figure 16. Global PD-1 and PD-L1 Drug Market: Liver Cancer (2021-2026) & (K Units)
Figure 17. PD-1 and PD-L1 Drug Consumed in Esophageal Cancer
Figure 18. Global PD-1 and PD-L1 Drug Market: Esophageal Cancer (2021-2026) & (K Units)
Figure 19. PD-1 and PD-L1 Drug Consumed in Nasal Cancer
Figure 20. Global PD-1 and PD-L1 Drug Market: Nasal Cancer (2021-2026) & (K Units)
Figure 21. PD-1 and PD-L1 Drug Consumed in Stomach Cancer
Figure 22. Global PD-1 and PD-L1 Drug Market: Stomach Cancer (2021-2026) & (K Units)
Figure 23. PD-1 and PD-L1 Drug Consumed in Other
Figure 24. Global PD-1 and PD-L1 Drug Market: Other (2021-2026) & (K Units)
Figure 25. Global PD-1 and PD-L1 Drug Sale Market Share by Application (2025)
Figure 26. Global PD-1 and PD-L1 Drug Revenue Market Share by Application in 2026
Figure 27. PD-1 and PD-L1 Drug Sales by Company in 2026 (K Units)
Figure 28. Global PD-1 and PD-L1 Drug Sales Market Share by Company in 2026
Figure 29. PD-1 and PD-L1 Drug Revenue by Company in 2026 ($ millions)
Figure 30. Global PD-1 and PD-L1 Drug Revenue Market Share by Company in 2026
Figure 31. Global PD-1 and PD-L1 Drug Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global PD-1 and PD-L1 Drug Revenue Market Share by Geographic Region in 2026
Figure 33. Americas PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 34. Americas PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 35. APAC PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 36. APAC PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 37. Europe PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 38. Europe PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 41. Americas PD-1 and PD-L1 Drug Sales Market Share by Country in 2026
Figure 42. Americas PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Figure 43. Americas PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 44. Americas PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 45. United States PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC PD-1 and PD-L1 Drug Sales Market Share by Region in 2026
Figure 50. APAC PD-1 and PD-L1 Drug Revenue Market Share by Region (2021-2026)
Figure 51. APAC PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 52. APAC PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 53. China PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. India PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe PD-1 and PD-L1 Drug Sales Market Share by Country in 2026
Figure 61. Europe PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Figure 62. Europe PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 63. Europe PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 64. Germany PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. France PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. UK PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 72. Egypt PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Drug in 2026
Figure 78. Manufacturing Process Analysis of PD-1 and PD-L1 Drug
Figure 79. Industry Chain Structure of PD-1 and PD-L1 Drug
Figure 80. Channels of Distribution
Figure 81. Global PD-1 and PD-L1 Drug Sales Market Forecast by Region (2027-2032)
Figure 82. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global PD-1 and PD-L1 Drug Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global PD-1 and PD-L1 Drug Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of PD-1 and PD-L1 Drug
Figure 2. PD-1 and PD-L1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PD-1 and PD-L1 Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global PD-1 and PD-L1 Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. PD-1 and PD-L1 Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2025)
Figure 10. PD-1 and PD-L1 Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of PD-1 Monoclonal Antibody
Figure 12. Product Picture of PD-L1 Monoclonal Antibody
Figure 13. Global PD-1 and PD-L1 Drug Sales Market Share by Type in 2026
Figure 14. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2021-2026)
Figure 15. PD-1 and PD-L1 Drug Consumed in Liver Cancer
Figure 16. Global PD-1 and PD-L1 Drug Market: Liver Cancer (2021-2026) & (K Units)
Figure 17. PD-1 and PD-L1 Drug Consumed in Esophageal Cancer
Figure 18. Global PD-1 and PD-L1 Drug Market: Esophageal Cancer (2021-2026) & (K Units)
Figure 19. PD-1 and PD-L1 Drug Consumed in Nasal Cancer
Figure 20. Global PD-1 and PD-L1 Drug Market: Nasal Cancer (2021-2026) & (K Units)
Figure 21. PD-1 and PD-L1 Drug Consumed in Stomach Cancer
Figure 22. Global PD-1 and PD-L1 Drug Market: Stomach Cancer (2021-2026) & (K Units)
Figure 23. PD-1 and PD-L1 Drug Consumed in Other
Figure 24. Global PD-1 and PD-L1 Drug Market: Other (2021-2026) & (K Units)
Figure 25. Global PD-1 and PD-L1 Drug Sale Market Share by Application (2025)
Figure 26. Global PD-1 and PD-L1 Drug Revenue Market Share by Application in 2026
Figure 27. PD-1 and PD-L1 Drug Sales by Company in 2026 (K Units)
Figure 28. Global PD-1 and PD-L1 Drug Sales Market Share by Company in 2026
Figure 29. PD-1 and PD-L1 Drug Revenue by Company in 2026 ($ millions)
Figure 30. Global PD-1 and PD-L1 Drug Revenue Market Share by Company in 2026
Figure 31. Global PD-1 and PD-L1 Drug Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global PD-1 and PD-L1 Drug Revenue Market Share by Geographic Region in 2026
Figure 33. Americas PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 34. Americas PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 35. APAC PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 36. APAC PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 37. Europe PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 38. Europe PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa PD-1 and PD-L1 Drug Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa PD-1 and PD-L1 Drug Revenue 2021-2026 ($ millions)
Figure 41. Americas PD-1 and PD-L1 Drug Sales Market Share by Country in 2026
Figure 42. Americas PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Figure 43. Americas PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 44. Americas PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 45. United States PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC PD-1 and PD-L1 Drug Sales Market Share by Region in 2026
Figure 50. APAC PD-1 and PD-L1 Drug Revenue Market Share by Region (2021-2026)
Figure 51. APAC PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 52. APAC PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 53. China PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. India PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe PD-1 and PD-L1 Drug Sales Market Share by Country in 2026
Figure 61. Europe PD-1 and PD-L1 Drug Revenue Market Share by Country (2021-2026)
Figure 62. Europe PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 63. Europe PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 64. Germany PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. France PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. UK PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Application (2021-2026)
Figure 72. Egypt PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries PD-1 and PD-L1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Drug in 2026
Figure 78. Manufacturing Process Analysis of PD-1 and PD-L1 Drug
Figure 79. Industry Chain Structure of PD-1 and PD-L1 Drug
Figure 80. Channels of Distribution
Figure 81. Global PD-1 and PD-L1 Drug Sales Market Forecast by Region (2027-2032)
Figure 82. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global PD-1 and PD-L1 Drug Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global PD-1 and PD-L1 Drug Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global PD-1 and PD-L1 Drug Revenue Market Share Forecast by Application (2027-2032)
